Trial Profile

A Randomised Controlled Trial for People With Established Type 2 Diabetes During Ramadan: Liraglutide vs. a Sulphonylurea

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 31 Jan 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Liraglutide (Primary) ; Metformin; Pioglitazone; Sulfonylureas
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Acronyms TREAT4Ramadan

Most Recent Events

26 Sep 2013 Results presented at the 49th Annual Meeting of the European Association for the Study of Diabetes.
20 Apr 2013 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
24 Dec 2012 Accrual to date is 103% according to United Kingdom Clinical Research Network.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com